Chronic Obstructive Pulmonary Disease
Research activity is centered on chronic obstructive pulmonary disease, with attention to patients at higher risk and to measures of clinical control that reflect both stability and symptom impact.
- COPD management
- Clinical control assessment
- Symptom stability and disease impact
The trial portfolio is focused on comparative treatment approaches for COPD in a single-country research setting with multiple collaborating sites across Spain.
Inhaled Therapy Strategies
Clinical interest includes inhaled maintenance therapy for COPD, especially comparisons between triple therapy and LABA-LAMA combination therapy in routine respiratory care.
- Triple therapy
- LABA-LAMA combinations
- Maintenance treatment for COPD
These studies align with therapeutic questions in pulmonary medicine where long-term control of airflow-related disease remains central.
Respiratory Outcomes Research
The sponsor’s research activity emphasizes respiratory outcomes that capture everyday disease burden, including validated composite measures used to evaluate treatment benefit in COPD.
- Composite clinical endpoints
- Patient-reported impact
- Disease stability
This area reflects a focus on clinically meaningful assessment within chronic respiratory disease management.
